Species . | Isolates (n) . | Observations (n) . | Source . | Origin . | Country . | Reference . |
---|---|---|---|---|---|---|
E. coli | 95 | 1520 | animal, food | surveillance | DK | Hendriksen et al.43 |
E. coli | 99 | 890 | animal, food | surveillance | UK | Duggett et al.44, AbuOun et al.48 |
E. colia | 390 | 2559 | human, animal | clinical, surveillance | DE | This study |
Salmonella enterica | 1081 | 7489 | animal, food | surveillance | USA | McDermott et al.23 |
C. jejuni | 239 | 1382 | animal, food | surveillance | FIN, FR, DE, LU, PL, PT | Leekitcharoenphon et al.45 |
E. faecium | 50 | 363 | human | clinical | DE | this study |
E. faeciumb | 56 | 159 | human | clinical | BE | this study |
E. faecalis | 50 | 235 | human and animal | clinical, surveillance | DE | Neumann et al.46, Bender et al.47 |
S. aureusb | 63 | 504 | human | clinical, surveillance | BE | this study |
S. aureusc | 100 | 598 | human | clinical, surveillance | DK | this study |
Species . | Isolates (n) . | Observations (n) . | Source . | Origin . | Country . | Reference . |
---|---|---|---|---|---|---|
E. coli | 95 | 1520 | animal, food | surveillance | DK | Hendriksen et al.43 |
E. coli | 99 | 890 | animal, food | surveillance | UK | Duggett et al.44, AbuOun et al.48 |
E. colia | 390 | 2559 | human, animal | clinical, surveillance | DE | This study |
Salmonella enterica | 1081 | 7489 | animal, food | surveillance | USA | McDermott et al.23 |
C. jejuni | 239 | 1382 | animal, food | surveillance | FIN, FR, DE, LU, PL, PT | Leekitcharoenphon et al.45 |
E. faecium | 50 | 363 | human | clinical | DE | this study |
E. faeciumb | 56 | 159 | human | clinical | BE | this study |
E. faecalis | 50 | 235 | human and animal | clinical, surveillance | DE | Neumann et al.46, Bender et al.47 |
S. aureusb | 63 | 504 | human | clinical, surveillance | BE | this study |
S. aureusc | 100 | 598 | human | clinical, surveillance | DK | this study |
If not otherwise specified, phenotypic AST results were obtained by BMD.
DK, Denmark; DE, Germany; FIN, Finland; FR, France; LU, Luxembourg; PL, Poland; PT, Portugal; BE, Belgium.
Dataset for blind test of ResFinder 4.0 performance. Cefepime, chloramphenicol, ertapenem and nalidixic acid susceptibility testing were performed by Etest in a subset of isolates. All remaining AST were performed by BMD.
Phenotypic AST results were obtained by Etest.
Phenotypic AST results were obtained by disc diffusion.
Species . | Isolates (n) . | Observations (n) . | Source . | Origin . | Country . | Reference . |
---|---|---|---|---|---|---|
E. coli | 95 | 1520 | animal, food | surveillance | DK | Hendriksen et al.43 |
E. coli | 99 | 890 | animal, food | surveillance | UK | Duggett et al.44, AbuOun et al.48 |
E. colia | 390 | 2559 | human, animal | clinical, surveillance | DE | This study |
Salmonella enterica | 1081 | 7489 | animal, food | surveillance | USA | McDermott et al.23 |
C. jejuni | 239 | 1382 | animal, food | surveillance | FIN, FR, DE, LU, PL, PT | Leekitcharoenphon et al.45 |
E. faecium | 50 | 363 | human | clinical | DE | this study |
E. faeciumb | 56 | 159 | human | clinical | BE | this study |
E. faecalis | 50 | 235 | human and animal | clinical, surveillance | DE | Neumann et al.46, Bender et al.47 |
S. aureusb | 63 | 504 | human | clinical, surveillance | BE | this study |
S. aureusc | 100 | 598 | human | clinical, surveillance | DK | this study |
Species . | Isolates (n) . | Observations (n) . | Source . | Origin . | Country . | Reference . |
---|---|---|---|---|---|---|
E. coli | 95 | 1520 | animal, food | surveillance | DK | Hendriksen et al.43 |
E. coli | 99 | 890 | animal, food | surveillance | UK | Duggett et al.44, AbuOun et al.48 |
E. colia | 390 | 2559 | human, animal | clinical, surveillance | DE | This study |
Salmonella enterica | 1081 | 7489 | animal, food | surveillance | USA | McDermott et al.23 |
C. jejuni | 239 | 1382 | animal, food | surveillance | FIN, FR, DE, LU, PL, PT | Leekitcharoenphon et al.45 |
E. faecium | 50 | 363 | human | clinical | DE | this study |
E. faeciumb | 56 | 159 | human | clinical | BE | this study |
E. faecalis | 50 | 235 | human and animal | clinical, surveillance | DE | Neumann et al.46, Bender et al.47 |
S. aureusb | 63 | 504 | human | clinical, surveillance | BE | this study |
S. aureusc | 100 | 598 | human | clinical, surveillance | DK | this study |
If not otherwise specified, phenotypic AST results were obtained by BMD.
DK, Denmark; DE, Germany; FIN, Finland; FR, France; LU, Luxembourg; PL, Poland; PT, Portugal; BE, Belgium.
Dataset for blind test of ResFinder 4.0 performance. Cefepime, chloramphenicol, ertapenem and nalidixic acid susceptibility testing were performed by Etest in a subset of isolates. All remaining AST were performed by BMD.
Phenotypic AST results were obtained by Etest.
Phenotypic AST results were obtained by disc diffusion.
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.